Sakiko. Shimizu, et.al., Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)., Journal of immunology (Baltimore, Md. : 1950), 2005, 175

http://rdf.ncbi.nlm.nih.gov/pubmed/16301622

Sakiko. Shimizu, et.al., Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1)., Journal of immunology (Baltimore, Md. : 1950), 2005, 175

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased IgE level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0002497MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased blood urea nitrogen level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0005566MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• increased circulating interleukin-4 level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0008602MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• increased IgG1 level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0008499MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased interferon-gamma secretion_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0008567MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased IgG2a level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0008496MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased anti-double stranded DNA antibody level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0004798MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• abnormal T-helper 2 physiology_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0005466MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased susceptibility to systemic lupus erythematosus_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0004802MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• increased circulating interleukin-5 level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0008626MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• decreased circulating creatinine level_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0005554MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• glomerulonephritis_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0002743MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak
• extended life span_Fas<lpr>/Fas<lpr>,Il27ra<tm1Mak>/Il27ra<tm1Mak>
  http://metadb.riken.jp/0001661MRLCgIl27ratm1MakFaslprFaslprFaslprIl27ratm1MakIl27ratm1MakFaslprIl27ratm1Mak